149 related articles for article (PubMed ID: 3141057)
1. The mode of recognition of tumor antigens by noncytolytic-type antitumor T cells: role of antigen-presenting cells and their surface class I and class II H-2 molecules.
Sakamoto K; Nakajima H; Shimizu J; Katagiri T; Kiyotaki C; Fujiwara H; Hamaoka T
Cancer Immunol Immunother; 1988; 27(3):261-6. PubMed ID: 3141057
[TBL] [Abstract][Full Text] [Related]
2. T-cell subsets, IFN-gamma production and efferent specificity in anti-parental tumor immunity induced by mouse sensitization with xenogenized variant cells.
Bianchi R; Fioretti MC; Romani L; Grohmann U; Cenci E; Puccetti P
Int J Cancer; 1990 Oct; 46(4):653-7. PubMed ID: 2120136
[TBL] [Abstract][Full Text] [Related]
3. Mechanisms for recognition of tumor antigens and mediation of anti-tumor effect by noncytolytic Lyt-2+ T cell subset.
Sakamoto K; Yoshioka T; Shimizu J; Sato S; Nakajima H; Fujiwara H; Hamaoka T
Jpn J Cancer Res; 1988 Jan; 79(1):99-108. PubMed ID: 3128511
[TBL] [Abstract][Full Text] [Related]
4. The activation of L3T4+ helper T cells assisting the generation of anti-tumor Lyt-2+ cytotoxic T lymphocytes: requirement of Ia-positive antigen-presenting cells for processing and presentation of tumor antigens.
Kosugi A; Yoshioka T; Suda T; Sano H; Takahama Y; Fujiwara H; Hamaoka T
J Leukoc Biol; 1987 Dec; 42(6):632-41. PubMed ID: 2960766
[TBL] [Abstract][Full Text] [Related]
5. Absence of the Lyt-2-,L3T4+ lineage of T cells in mice treated neonatally with anti-I-A correlates with absence of intrathymic I-A-bearing antigen-presenting cell function.
Kruisbeek AM; Mond JJ; Fowlkes BJ; Carmen JA; Bridges S; Longo DL
J Exp Med; 1985 May; 161(5):1029-47. PubMed ID: 3921649
[TBL] [Abstract][Full Text] [Related]
6. T cell subsets and IFN-gamma production in resistance to systemic candidosis in immunized mice.
Cenci E; Romani L; Vecchiarelli A; Puccetti P; Bistoni F
J Immunol; 1990 Jun; 144(11):4333-9. PubMed ID: 1971296
[TBL] [Abstract][Full Text] [Related]
7. Requirement for recognition of class II molecules and processed tumor antigen for optimal generation of syngeneic tumor-specific class I-restricted CTL.
Kern DE; Klarnet JP; Jensen MC; Greenberg PD
J Immunol; 1986 Jun; 136(11):4303-10. PubMed ID: 2422280
[TBL] [Abstract][Full Text] [Related]
8. Expansion of tumor-specific cytolytic T lymphocytes using in vitro restimulation with tumor-specific transplantation antigen.
Naito K; Pellis NR; Kahan BD
Cell Immunol; 1987 Sep; 108(2):483-94. PubMed ID: 3113743
[TBL] [Abstract][Full Text] [Related]
9. Properties of purified T cell subsets. I. In vitro responses to class I vs. class II H-2 alloantigens.
Sprent J; Schaefer M
J Exp Med; 1985 Dec; 162(6):2068-88. PubMed ID: 2933483
[TBL] [Abstract][Full Text] [Related]
10. Studies on macrophage-activating factor (MAF) in antitumor immune responses. II. Molecular characterization of MAF produced by the tumor-immune Lyt-1+2- T cell subset.
Nakajima H; Izumi Y; Sugihara S; Satoh Y; Isumi S; Gotoh T; Fujiwara H; Hamaoka T
Cancer Immunol Immunother; 1987; 25(3):201-8. PubMed ID: 3119213
[TBL] [Abstract][Full Text] [Related]
11. Tumor-specific T cell lines: capacity to proliferate and produce interleukin 2 in response to various forms of tumor antigens.
Shimizu J; Suda T; Katagiri T; Fujiwara H; Hamaoka T
Jpn J Cancer Res; 1992 Feb; 83(2):184-93. PubMed ID: 1372887
[TBL] [Abstract][Full Text] [Related]
12. Characterization of two distinct primary T cell populations that secrete interleukin 2 upon recognition of class I or class II major histocompatibility antigens.
Mizuochi T; Ono S; Malek TR; Singer A
J Exp Med; 1986 Mar; 163(3):603-19. PubMed ID: 2936862
[TBL] [Abstract][Full Text] [Related]
13. Clonal analysis of cytolytic T lymphocyte-mediated lysis of target cells with inducible antigen expression: correlation between antigen density and requirement for Lyt-2/3 function.
Shimonkevitz R; Luescher B; Cerottini JC; MacDonald HR
J Immunol; 1985 Aug; 135(2):892-9. PubMed ID: 2409156
[TBL] [Abstract][Full Text] [Related]
14. Requirements for the generation of a Lyt-2+ T-cell proliferative response to a syngeneic tumor in the absence of L3T4+ T-cells.
Kern DE; Klarnet JP; Cheever MA; Greenberg PD
Cancer Res; 1990 Oct; 50(19):6256-63. PubMed ID: 2144789
[TBL] [Abstract][Full Text] [Related]
15. The role of L3T4 in T cell activation: L3T4 may be both an Ia-binding protein and a receptor that transduces a negative signal.
Tite JP; Sloan A; Janeway CA
J Mol Cell Immunol; 1986; 2(4):179-90. PubMed ID: 3509916
[TBL] [Abstract][Full Text] [Related]
16. Role of L3T4+ and LyT-2+ cells in experimental visceral leishmaniasis.
Stern JJ; Oca MJ; Rubin BY; Anderson SL; Murray HW
J Immunol; 1988 Jun; 140(11):3971-7. PubMed ID: 3131421
[TBL] [Abstract][Full Text] [Related]
17. Cellular pathways for rejection of class-I-MHC--disparate skin and tumor allografts.
Smith DM; Stuart FP; Wemhoff GA; Quintáns J; Fitch FW
Transplantation; 1988 Jan; 45(1):168-75. PubMed ID: 3276046
[TBL] [Abstract][Full Text] [Related]
18. Tolerance induction of allo-class II H-2 antigen-reactive L3T4+ helper T cells and prolonged survival of the corresponding class II H-2-disparate skin graft.
Hori S; Sato S; Kitagawa S; Azuma T; Kokudo S; Hamaoka T; Fujiwara H
J Immunol; 1989 Sep; 143(5):1447-52. PubMed ID: 2527264
[TBL] [Abstract][Full Text] [Related]
19. Requirements for T cell recognition and elimination of retrovirally-transformed cells.
Greenberg P; Klarnet J; Kern D; Okuno K; Riddell S; Cheever M
Princess Takamatsu Symp; 1988; 19():287-301. PubMed ID: 2479634
[TBL] [Abstract][Full Text] [Related]
20. Antigen-presenting cells for Lyt-2+ cells. I. Stimulation of unprimed Lyt-2+ cells by H-2 different Thy-1-Ia- cells prepared from spleen and bone marrow.
Sprent J; Schaefer M
J Immunol; 1988 Jun; 140(11):3745-50. PubMed ID: 2897393
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
